Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Thromboprophylaxis in Critically Ill Patients: a Prospective, Randomized Study Comparing Anti-Xa Activities Following Subcutaneous Administration of 5000 IU and 7500 IU Dalteparin

NCT00437697 is registered in ClinicalTrials.gov with Medical University of Vienna as lead sponsor.

NCT NCT00437697
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00437697 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Thromboprophylaxis in Critically Ill Patients: a Prospective, Randomized Study Comparing Anti-Xa Activities Following Subcutaneous Administration of 5000 IU and 7500 IU Dalteparin
Lead sponsor
Medical University of Vienna
Phase
Phase 4
Overall status
Terminated
Start date
April 30, 2003
Completion date
April 30, 2005
Enrollment
90
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

venous thromboembolism